» Articles » PMID: 9430372

Human Beta-migrating Very Low Density Lipoprotein Induces Foam Cell Formation in Human Mesangial Cells

Overview
Journal Atherosclerosis
Publisher Elsevier
Date 1998 Jan 16
PMID 9430372
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

To elucidate the mechanism of foam cell formation in the mesangial region of a kidney observed in a familial type III hyperlipoproteinemic patient presenting with diabetes mellitus and nephrotic syndrome, we have examined, in the present study, the effect of human beta-VLDL (apo E2/E2) on foam cell formation in human mesangial cells, since an increase in beta-VLDL is a characteristic feature of this patient. Human beta-VLDL (apo E2/E2) induced foam cell formation in human mesangial cells. The binding of [125I]LDL to human mesangial cells was inhibited completely by both LDL and beta-VLDL. On the other hand, the binding of [125I]beta-VLDL was completely inhibited by beta-VLDL, but partially by LDL. The LDL receptor, but not the VLDL receptor was down-regulated by accumulation of cholesteryl esters. These results suggest that human beta-VLDL (apo E2/E2)-induced foam cell formation in mesangial cells is mediated through both the LDL receptor pathway and the beta-VLDL specific pathway, in which the VLDL receptor is one of the candidates.

Citing Articles

Cellular cholesterol transport proteins in diabetic nephropathy.

Tsun J, Yung S, Chau M, Shiu S, Chan T, Tan K PLoS One. 2014; 9(9):e105787.

PMID: 25181357 PMC: 4152117. DOI: 10.1371/journal.pone.0105787.


Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation.

Rohde E, Schallmoser K, Reinisch A, Hofmann N, Pfeifer T, Frohlich E Cytotherapy. 2010; 13(4):503-12.

PMID: 21128706 PMC: 3173858. DOI: 10.3109/14653249.2010.536214.


Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study.

Davis T, Ting R, Best J, Donoghoe M, Drury P, Sullivan D Diabetologia. 2010; 54(2):280-90.

PMID: 21052978 DOI: 10.1007/s00125-010-1951-1.